Liposomes—microscopic phospholipid bubbles with a bilayered membrane structure—have
received a lot of attention during the past 30 years as pharmaceutical carriers of great …

Currently used pharmaceutical nanocarriers, such as liposomes, micelles, nanoemulsions,
polymeric nanoparticles and many others demonstrate a broad variety of useful properties …

The use of various pharmaceutical nanocarriers has become one of the most important
areas of nanomedicine. Ideally, such carriers should be specifically delivered (targeted) to …

The paradigm of using nanoparticulate pharmaceutical carriers has been well established
over the past decade, both in pharmaceutical research and in the clinical setting. Drug …

Branched polyethylenimine (PEI) chains with an average molecular mass of 2 kDa (PEI2)
have been covalently attached to gold nanoparticles (GNPs), and the potency of the …

We studied the molecular mechanism of greater efficacy of paclitaxel-loaded nanoparticles
(Tx-NPs) following conjugation to transferrin (Tf) ligand in breast cancer cell line. NPs were …

Chemotherapy remains the preferred choice of treatment for prostate cancer but modest
drug response and significant toxicity by conventional methods of administration limit their …

The purpose of this review is to provide an insight into the different aspects of pH‐sensitive
liposomes. The review consists of 6 parts: the first introduces different types of medications …

Background: Liposomes, phospholipids, nanosized bubbles with a bilayered membrane
structure, have drawn a lot of interest as pharmaceutical carriers for drugs and genes. In …

To develop nonviral gene vectors that are sufficient for clinical application, it is necessary to
understand why and to what extent nonviral vectors are inferior to viral vectors, which in …